Discover
COLL
Collegium Pharmaceutical, Inc.
22.77
2 x 16.31
2 x 28.64
bid
ask
+
0.39
1.74%
2 @ 07:30 PM
22.77 +0.00 (0.00%)
| Ytd | -50.82% | |
| 1y | -37.03% |
22.07
day range
22.93
21.84
52 week range
49.84
| Open | 22.17 | Prev Close | 22.38 | Low | 22.07 | High | 22.93 | Mkt Cap | 705.85M |
| Vol | 1.99M | Avg Vol | 674.77K | EPS | 1.27 | P/E | 17.93 | Forward P/E | 4.86 |
| Beta | 0.73 | Short Ratio | 11.92 | Inst. Own | 128.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 29.65 | 200-d Avg | 37.15 | 1yr Est | 53.60 |
| Income Statement | |||
| Total Revenue | 199.88M | ||
| Revenues (USD) | 199.88M | ||
| Cost of Revenue | 89.59M | ||
| Gross Profit | 110.29M | ||
| Operating Expenses | 106.59M | ||
| Selling, General and Administrative Expense | 106.59M | ||
| Operating Income | 3.70M | ||
| Interest Expense | 19.52M | ||
| Income Tax Expense | 1.52M | ||
| Net Income | -15.05M | ||
| Net Income Common Stock | -15.05M | ||
| Net Income Common Stock (USD) | -15.05M | ||
| Consolidated Income | -15.05M | ||
| Earnings per Basic Share | -0.46 | ||
| Earnings per Basic Share (USD) | -0.46 | ||
| Earnings per Diluted Share | -0.46 | ||
| Earning Before Interest & Taxes (EBIT) | 5.99M | ||
| Earning Before Interest & Taxes (USD) | 5.99M | ||
| Weighted Average Shares | 32.46M | ||
| Weighted Average Shares Diluted | 32.46M | ||
| Balance Sheet | |||
| Cash and Equivalents | 150.38M | ||
| Cash and Equivalents (USD) | 150.38M | ||
| Trade and Non-Trade Receivables | 285.10M | ||
| Current Assets | 608.01M | ||
| Property, Plant & Equipment Net | 14.44M | ||
| Total Assets | 2.14B | ||
| Debt Current | 56.56M | ||
| Total Debt | 1.10B | ||
| Current Liabilities | 589.86M | ||
| Debt Non-Current | 1.04B | ||
| Total Liabilities | 1.82B | ||
| Accumulated Retained Earnings (Deficit) | -101.68M | ||
| Shareholders Equity | 311.91M | ||
| Shareholders Equity (USD) | 311.91M | ||
| Assets Non-Current | 1.53B | ||
| Total Debt (USD) | 1.10B | ||
| Deferred Revenue | 9.45M | ||
| Goodwill and Intangible Assets | 1.38B | ||
| Inventory | 113.27M | ||
| Liabilities Non-Current | 1.23B | ||
| Trade and Non-Trade Payables | 9.24M | ||
| Tax Assets | 120.77M | ||
| Tax Liabilities | 40.97M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.81M | ||
| Net Cash Flow from Financing | 292.09M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -139.18M | ||
| Capital Expenditure | -496.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -655.40M | ||
| Issuance (Purchase) of Equity Shares | 481.00K | ||
| Issuance (Repayment) of Debt Securities | 292.25M | ||
| Net Cash Flow from Investing | -502.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 153.31M | ||
| Net Cash Flow from Operations | 71.32M | ||
| Share Based Compensation | 14.48M | ||